In addition, knockdown of STK33 in KRAS mutant epithelial cancer cell lines from different origins (including colorectal, breast, and pancreatic cancers) led to impaired colony formation in vitro and slower growth in vivo. This evidence concerns the gene STK33 and pancreatic neoplasm.